Seguici
IT
IT

Uno degli obiettivi principali di Life4me+ è quello di prevenire nuovi casi di HIV e altre infezioni sessualmente trasmissibili, epatite C e tubercolosi.

L'app aiuta a stabilire una comunicazione anonima tra i medici e le persone sieropositive. Ti consente di organizzare comodamente l'orario di assunzione dei farmaci e di impostare promemoria nascosti e personalizzati.

Tutte le notizie

Archivio

✕
12 dicembre 2017
3702
BRICS Countries Are Making Progress Towards Universal Health Coverage

BRICS Countries Are Making Progress Towards Universal Health Coverage

The emerging economies of Brazil, Russia, India, China and South Africa — representing almost half the world’s population — are all taking steps toward Universal Health Coverage.
12 dicembre 2017
3877
Kazatchkine appointed UNAIDS Special Adviser

Kazatchkine appointed UNAIDS Special Adviser

Michel Kazatchkine appointed UNAIDS Special Adviser on HIV, Tuberculosis and Hepatitis C in Eastern Europe and Central Asia.
11 dicembre 2017
3523
New hepatitis C therapy approved in UK

New hepatitis C therapy approved in UK

Maviret (Glecaprevir-pibrentasvir) has been recommended for adults with chronic hepatitis C. The treatment is an additional option suitable for all genotypes, with or without scarring of the liver, and in people who are untreated or have been treated before with interferon-based ...
11 dicembre 2017
3463
Grantmaking for HIV Totaled a Record $680 Million

Grantmaking for HIV Totaled a Record $680 Million

Global philanthropic support for HIV/AIDS initiatives totaled a record $680 million in 2016. The top twenty funders accounted for 87 percent of 2016 resources. The top recipient of country-level philanthropic funding for HIV/AIDS initiatives was the U.S.
11 dicembre 2017
3242
UNAIDS and IOM signed a partnership agreement

UNAIDS and IOM signed a partnership agreement

UNAIDS and the International Organization for Migration signed a new cooperation agreement to promote access to HIV prevention, treatment, care and support services for migrants, mobile populations and people affected by humanitarian emergencies.
8 dicembre 2017
3936
NIH launches HIV prevention trial of long-acting injectable cabotegravir compared with daily oral PrEP

NIH launches HIV prevention trial of long-acting injectable cabotegravir compared with daily oral PrEP

The first large-scale clinical trial of a long-acting injectable medication for HIV prevention in sexually active women has begun. The study will examine whether a long-acting form of the investigational anti-HIV drug cabotegravir injected once every eight weeks can safely ...
8 dicembre 2017
3688
Tilda Swinton supports the groundbreaking French HIV treatment

Tilda Swinton supports the groundbreaking French HIV treatment

ICCARRE is a groundbreaking programme reducing the amount of medication required by HIV/AIDS patients during treatment. It presents a short film directed by Blanca Li and starring Tilda Swinton.
7 dicembre 2017
3494
Higher risk sexual behaviour is associated with unawareness of HIV-positivity

Higher risk sexual behaviour is associated with unawareness of HIV-positivity

People with HIV who don't use condoms consistently are more likely to be unaware they are HIV-positive or to have a detectable viral load when their HIV infection has been diagnosed.
7 dicembre 2017
3744
Older antiretroviral regimens raise diabetes risk in HIV-positive

Older antiretroviral regimens raise diabetes risk in HIV-positive

HIV-positive adults who initiated older formulations of antiretroviral therapy are more likely to develop type 2 diabetes than patients who initiated therapy between 2010 and 2015, according to findings from the Canadian study.
7 dicembre 2017
3468
Smoking presents a greater risk to HIV-positive people than HIV itself

Smoking presents a greater risk to HIV-positive people than HIV itself

HIV-positive people smoke at more than twice the rate of the general population in the US. Doctors say smoking now presents a greater risk to them than HIV itself.
Utilizziamo i cookie su questo sito per migliorare la tua esperienza.
Facendo clic su qualsiasi pulsante di questo sito Web, dai il tuo consenso per l'impostazione dei cookie.